Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and immunogenicity of inactivated COVID‐19 vaccine in health care workers
Saovanee Benjamanukul, Sasiwimon Traiyan, Ritthideach Yorsaeng, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1442-1449
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 86-86
Open Access | Times Cited: 85
Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study
Nasamon Wanlapakorn, Nungruthai Suntronwong, Harit Phowatthanasathian, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 65
Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals
Nicolás A. Muena, Tamara García‐Salum, Catalina Pardo‐Roa, et al.
EBioMedicine (2022) Vol. 78, pp. 103972-103972
Open Access | Times Cited: 45
Immunogenicity of ChAdOx1 nCoV-19 Booster Vaccination Following Two CoronaVac Shots in Healthcare Workers
Wisit Prasithsirikul, Krit Pongpirul, Tanawin Nopsopon, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 217-217
Open Access | Times Cited: 15
How has research on the effectiveness and safety of COVID-19 vaccination been evaluated: a scope review with emphasis on CoronaVac
Juan Carlos Alzate-Ángel, Paula A. Avilés-Vergara, David Arango-Londoño, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 2
The Relationship between Attitudes and Satisfaction Concerning the COVID-19 Vaccine and Vaccine Boosters in Urban Bangkok, Thailand: A Cross-Sectional Study
Jadsada Kunno, Busaba Supawattanabodee, Chavanant Sumanasrethakul, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 9, pp. 5086-5086
Open Access | Times Cited: 7
Antibody dynamics post-Comirnaty and CoronaVac vaccination in Malaysia
Cheng Siang Tan, Vaenessa Noni, Whilemena Upam Herman Ulok Melina, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Adverse Events Following Immunization (AEFI) with CoronaVac COVID-19 Vaccine among Clinical Clerkship Students at the Faculty of Medicine, Syarif Hidayatullah State Islamic University, Jakarta, Indonesia
Femmy Nurul Akbar, Risahmawati Risahmawati, Nurin Nadzifatil Fitriyah, et al.
Bangladesh Journal of Medical Science (2023) Vol. 22, Iss. 3, pp. 545-552
Open Access | Times Cited: 3
Safety profile of inactivated COVID-19 vaccine in indonesian adults
Hindra Irawan Satari, Nastiti Kaswandani, Bernie Endyarni Medise, et al.
Vaccine X (2023) Vol. 14, pp. 100331-100331
Open Access | Times Cited: 2
Anaphylaxis is rare due to CoronaVac in a population of healthcare workers
Betül Özdel Öztürk, İrem Akdemir Kalkan, Alpay Azap, et al.
Asia Pacific Allergy (2022) Vol. 12, Iss. 4, pp. e35-e35
Open Access | Times Cited: 4
Durability of the Effectiveness of Heterologous COVID-19 Vaccine Regimens in Thailand: Retrospective Cohort Study Using National Registration Data
Ponlagrit Kumwichar, Chittawan Poonsiri, Siobhan Botwright, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e48255-e48255
Open Access
Unveiling the micronutrient‐immunity puzzle in inactivated COVID‐19 vaccination: A comprehensive analysis of circulating micronutrient levels and humoral responses in healthy adults
Huicui Meng, Yin Wang, Yanmei Zhai, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Closed Access
High SARS-CoV-2 infection rate in children unvaccinated with COVID-19 vaccine in Changzhou, China, shortly after lifting zero-COVID-19 policy in December 2022
Jie Tang, Yong Wang, Weiqin Lu, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
COVID‐19 Vaccination in Patients With Systemic Lupus Erythematosus: Adverse Events and Rating Agreement of Flares Between Patients and Physicians
Punsita Tangkum, Nuntana Kasitanon, Wanitcha Gumtorntip, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 12
Closed Access
Satisfaction with COVID-19 Vaccines in Health Care Workers and the General Population: A Cross-Sectional Study in Urban Bangkok, Thailand
Jadsada Kunno, Pataraporn Yubonpunt, Chavanant Sumanasrethakul, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1345-1345
Open Access | Times Cited: 3
Comparison of Antibody Persistence Up to 6 Months After Additional Booster Vaccination With ChAdOx1 nCoV-19 Vaccine.
Pawita Suwanwattana, May Han, Tanawin Nopsopon, et al.
(2023)
Open Access | Times Cited: 1
Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients
Anussara Prayongrat, Patjaya Noppaving, Thitiporn Chobarporn, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1135-1135
Open Access | Times Cited: 1
Safety of Inactivated SARS-CoV-2 Vaccines Among Adults with Experience of Allergies to Food or Medicines
Yan Jin, Mengmeng Zheng, Shiyi He, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 3105-3113
Open Access | Times Cited: 1
ADVERSE EVENTS FOLLOWING VACCINATION WITH A VIRAL VECTOR-BASED VACCINE - A CROSS-SECTIONAL STUDY
Vanya Rangelova, Zhivka Getsova
PROBLEMS of Infectious and Parasitic Diseases (2023) Vol. 51, Iss. 1, pp. 19-25
Open Access | Times Cited: 1
Safety profile of inactivated COVID-19 in healthy adults aged ≥ 18 years: A passive surveillance in Indonesia
Nastiti Kaswandani, Bernie Endyarni Medise, Elcha Leonard, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0286484-e0286484
Open Access | Times Cited: 1
COVID-19 Vaccine Hesitancy and Self-reported Adverse Effects: A Narrative Review
N. Noh, Mahmathi Karuppannan
Malaysian Journal of Medicine and Health Sciences (2023) Vol. 19, Iss. s12, pp. 79-88
Open Access | Times Cited: 1
Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated vaccine
Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Antibody response to SARS-CoV-2 vaccines among hospitalized patients in China: a case-control study
Feiping Li, Guifeng Shi, Zhenzhen Lin, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 1
Reações adversas pós-vacinação por COVID-19: uma revisão integrativa
Isabela Correa, Milena Alves Pereira, Kelly Cristina Suzue Iamaguchi Luz, et al.
Research Society and Development (2022) Vol. 11, Iss. 13, pp. e188111335278-e188111335278
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top